Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. - Wikidata - wikimedia - TriplyDB

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

http://www.wikidata.org/entity/Q36508891

about

Nanoengineering approaches to the design of artificial antigen-presenting cells Micro and nanoparticle drug delivery systems for preventing allotransplant rejection Optimized staining and proliferation modeling methods for cell division monitoring using cell tracking dyes An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.Biomimetic delivery with micro- and nanoparticles A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Surface engineering for lymphocyte programming.Fas mediates cardiac allograft acceptance in mice with impaired T-cell-intrinsic NF-kappaB signaling.Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model.Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.

P2860

Q27023634-BD670C19-EBEF-4D61-9651-E71D571421E5 Q28080720-773F1995-C6EC-4162-9F0E-DF8176A677D8 Q28681906-EAF44939-A72E-4B8A-8474-0CB26A18CBC3 Q33780582-16FF92B7-1EF8-41C3-B15D-660FC5531991 Q34139182-DC5EE145-2A5D-4095-BAFE-5D55FB2C79C4 Q34175958-0F3F0A6E-7A2E-4AEE-9EB3-312640D3D78D Q36279715-D8BB8342-DF3E-45D7-A351-686E13C982A7 Q36383130-CA6DA195-B717-42FC-A8C2-056F41798D81 Q36454872-C110BE8C-D47E-447B-A9A8-F10D28E9AEE9 Q36768786-08E2A266-2601-4EC5-A455-DBA59C4C3DDA Q37022139-2A7FF9B0-41AB-4423-8751-7643E273C98A Q37177987-3536136F-8560-4D21-9BA8-EC2A53FCFF30 Q37678250-3B3CBF3A-DF2F-4BB2-8C55-0295A09474B9 Q38645059-F7D03D96-E7AD-41B9-AD29-13F6DA7FBA7F Q40044791-7B88D95B-093D-409A-A1F7-FA9FC253FE18 Q40214162-7B0DB56F-1F90-4A86-AEC2-C1313A01D5FD Q40407883-7BFF18F0-13E3-4B39-90F0-0C2FA94CF8F1 Q40975411-1F2D2AEE-FBC6-4B48-AE95-6F530855A1C0 Q42752862-FF11DDF5-F2C1-497E-8AEC-CEEFF1026823 Q50526246-E4573253-69C5-4D3F-B95C-0BE8ED28A9F0 Q52366029-1795F063-7871-4407-9BEA-13C1B176D1FA

P2860

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

http://www.wikidata.org/entity/Q36508891

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@ast

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@en

type

label

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@ast

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@en

prefLabel

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@ast

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@en

P1433

Q36508891-8786C37C-8681-4F5E-95CD-4A55594172C5

P1476

Q36508891-B51FDF35-3A77-42EE-919A-E51343D9A81F

P2093

Q36508891-5B319260-17D2-441F-B44D-24DEA3FDBB93

Q36508891-8DE56B00-49E1-46B7-AD00-D5CD03FD517C

Q36508891-BBBE57DC-C544-4D8D-8452-34DD82C48C2E

Q36508891-D0230D1A-0015-4C1E-9B4A-FFECB55B0C11

Q36508891-E69B12A8-6B43-46CA-B7B8-5561910E7F0C

Q36508891-F329D1D8-1628-438D-96BF-7FA0B6718E65

Q36508891-FB8F2485-0D64-4F77-AD34-29C81B6B0478

P2860

Q36508891-2378E26C-F27D-43B3-9D73-ED05A63635AF

Q36508891-358BD008-9269-439B-B46C-C08C7C6DFBF2

Q36508891-398C10CD-7C77-4E0C-A7BE-283959B2AB33

Q36508891-48800970-5A4A-4743-98FF-D57B9A294897

Q36508891-4BF9B706-A111-4C4D-8539-B0E2F46B257F

Q36508891-4EEA4F82-6E56-4104-B831-9F26566C1413

Q36508891-4F2C9C8C-AF4F-4B5E-8ADE-B2B8684589A2

Q36508891-50AB7B34-7599-451E-81A7-743BA025E03F

Q36508891-51E70F9B-897E-4FF9-895F-D3F0F2A56C63

Q36508891-5A3AB05F-A3CD-4F95-8866-CADE3537FC95

P304

Q36508891-2B7BFA75-E754-452C-8D79-564AD4AA44AC

P31

Q36508891-5DA740E4-38ED-4970-B1E4-217CB8FFF8A8

P356

Q36508891-5A8DDDDC-CA91-44F9-8587-C69BE2FA5E94

P407

Q36508891-82DF47AB-C865-4DD5-A9D9-3F4422386DF6

P433

Q36508891-7289F784-A996-49AE-B894-C84E4DAF4B29

P478

Q36508891-C0F3B8C1-D772-449D-A293-6399FFD895FB

P577

Q36508891-01BA1CBC-32AD-4B44-8E97-86ECF0744ED8

P5875

Q36508891-691B26DC-5445-440E-B4F6-29701CB5F4DF

P698

Q36508891-B3804678-98A0-4034-B0D9-0574FCF3E3E4

P932

Q36508891-EAB983BD-16B7-4EBC-995E-D0854C130092

P356

BLOOD-2007-09-113522

P1433

P1476

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

@en

P2093

Alessia Zoso

http://www.w3.org/2001/XMLSchema#string

Andreas Mackensen

http://www.w3.org/2001/XMLSchema#string

Christian Schütz

http://www.w3.org/2001/XMLSchema#string

Dagmar Halbritter

http://www.w3.org/2001/XMLSchema#string

Jonathan P Schneck

http://www.w3.org/2001/XMLSchema#string

Martin Fleck

http://www.w3.org/2001/XMLSchema#string

Mathias Oelke

http://www.w3.org/2001/XMLSchema#string

P2860

CD95's deadly mission in the immune system

The B7 family revisited

Apoptosis by death factor

Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.

Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes

Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers.

Tumor counterattack: fact or fiction?

HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.

The evolution of adaptive immune systems.

Epitope spreading in immune-mediated diseases: implications for immunotherapy.

P304

3546-3552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-09-113522

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5751879

http://www.w3.org/2001/XMLSchema#string

P698

18096763

http://www.w3.org/2001/XMLSchema#string

P932

2275020

http://www.w3.org/2001/XMLSchema#string